SEC Filings

Investor Contacts

Katherine A. Littrell, PhD, RN
Vice President, Investor Relations

Diane H. Schrick
Senior Director, Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filings

Filing date Form Description Filing Group View
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
S-8

Securities offered to employees pursuant to employee benefit plans

Registration Statements
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
424B4

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

Registration Statements
View HTML
FWP

FWP

Other
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML

Copyright Morningstar